BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 17541642)

  • 1. High-density single nucleotide polymorphism array analysis in patients with germline deletions of 22q11.2 and malignant rhabdoid tumor.
    Jackson EM; Shaikh TH; Gururangan S; Jones MC; Malkin D; Nikkel SM; Zuppan CW; Wainwright LM; Zhang F; Biegel JA
    Hum Genet; 2007 Sep; 122(2):117-27. PubMed ID: 17541642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic analysis using high-density single nucleotide polymorphism-based oligonucleotide arrays and multiplex ligation-dependent probe amplification provides a comprehensive analysis of INI1/SMARCB1 in malignant rhabdoid tumors.
    Jackson EM; Sievert AJ; Gai X; Hakonarson H; Judkins AR; Tooke L; Perin JC; Xie H; Shaikh TH; Biegel JA
    Clin Cancer Res; 2009 Mar; 15(6):1923-30. PubMed ID: 19276269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors.
    Hasselblatt M; Isken S; Linge A; Eikmeier K; Jeibmann A; Oyen F; Nagel I; Richter J; Bartelheim K; Kordes U; Schneppenheim R; Frühwald M; Siebert R; Paulus W
    Genes Chromosomes Cancer; 2013 Feb; 52(2):185-90. PubMed ID: 23074045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors.
    Eaton KW; Tooke LS; Wainwright LM; Judkins AR; Biegel JA
    Pediatr Blood Cancer; 2011 Jan; 56(1):7-15. PubMed ID: 21108436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide approach to identify second gene targets for malignant rhabdoid tumors using high-density oligonucleotide microarrays.
    Takita J; Chen Y; Kato M; Ohki K; Sato Y; Ohta S; Sugita K; Nishimura R; Hoshino N; Seki M; Sanada M; Oka A; Hayashi Y; Ogawa S
    Cancer Sci; 2014 Mar; 105(3):258-64. PubMed ID: 24418192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors.
    Biegel JA; Tan L; Zhang F; Wainwright L; Russo P; Rorke LB
    Clin Cancer Res; 2002 Nov; 8(11):3461-7. PubMed ID: 12429635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of distal 22q11.2 deletion syndrome in a patient with a teratoid/rhabdoid tumour.
    Beddow RA; Smith M; Kidd A; Corbett R; Hunter AG
    Eur J Med Genet; 2011; 54(3):295-8. PubMed ID: 21187175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital anomalies and rhabdoid tumor associated with 22q11 germline deletion and somatic inactivation of the SMARCB1 tumor suppressor.
    Toth G; Zraly CB; Thomson TL; Jones C; Lapetino S; Muraskas J; Zhang J; Dingwall AK
    Genes Chromosomes Cancer; 2011 Jun; 50(6):379-88. PubMed ID: 21412926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SMARCB1 deletion by a complex three-way chromosomal translocation in an extrarenal malignant rhabdoid tumor.
    Bahrami A; Lee S; Caradine KD; Raimondi SC; Folpe AL
    Cancer Genet; 2014 Sep; 207(9):437-40. PubMed ID: 25312828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome.
    Frühwald MC; Hasselblatt M; Wirth S; Köhler G; Schneppenheim R; Subero JI; Siebert R; Kordes U; Jürgens H; Vormoor J
    Pediatr Blood Cancer; 2006 Sep; 47(3):273-8. PubMed ID: 16206192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel germ-line deletion of SNF5/INI1/SMARCB1 gene in neonate presenting with congenital malignant rhabdoid tumor of kidney and brain primitive neuroectodermal tumor.
    Kusafuka T; Miao J; Yoneda A; Kuroda S; Fukuzawa M
    Genes Chromosomes Cancer; 2004 Jun; 40(2):133-9. PubMed ID: 15101046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors.
    Rousseau-Merck MF; Versteege I; Legrand I; Couturier J; Mairal A; Delattre O; Aurias A
    Cancer Res; 1999 Jul; 59(13):3152-6. PubMed ID: 10397258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrations of the hSNF5/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumors.
    Uno K; Takita J; Yokomori K; Tanaka Y; Ohta S; Shimada H; Gilles FH; Sugita K; Abe S; Sako M; Hashizume K; Hayashi Y
    Genes Chromosomes Cancer; 2002 May; 34(1):33-41. PubMed ID: 11921280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations.
    Sévenet N; Lellouch-Tubiana A; Schofield D; Hoang-Xuan K; Gessler M; Birnbaum D; Jeanpierre C; Jouvet A; Delattre O
    Hum Mol Genet; 1999 Dec; 8(13):2359-68. PubMed ID: 10556283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital extrarenal malignant rhabdoid tumor in an infant with distal 22q11.2 deletion syndrome: the importance of SMARCB1.
    Chakrapani AL; White CR; Korcheva V; White K; Lofgren S; Zonana J; Moore S; Krol A; Mansoor A
    Am J Dermatopathol; 2012 Aug; 34(6):e77-80. PubMed ID: 22814326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas.
    Modena P; Lualdi E; Facchinetti F; Galli L; Teixeira MR; Pilotti S; Sozzi G
    Cancer Res; 2005 May; 65(10):4012-9. PubMed ID: 15899790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Goldenhar phenotype in a child with distal 22q11.2 deletion and intracranial atypical teratoid rhabdoid tumor.
    Lafay-Cousin L; Payne E; Strother D; Chernos J; Chan M; Bernier FP
    Am J Med Genet A; 2009 Dec; 149A(12):2855-9. PubMed ID: 19938088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas.
    Perry A; Fuller CE; Judkins AR; Dehner LP; Biegel JA
    Mod Pathol; 2005 Jul; 18(7):951-8. PubMed ID: 15761491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translocation (1;22)(p36;q11.2) with concurrent del(22)(q11.2) resulted in homozygous deletion of SNF5/INI1 in a newly established cell line derived from extrarenal rhabdoid tumor.
    Misawa A; Hosoi H; Imoto I; Iehara T; Sugimoto T; Inazawa J
    J Hum Genet; 2004; 49(10):586-589. PubMed ID: 15378398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosome 22q deletions in atypical teratoid/rhabdoid tumors in adults.
    Raisanen J; Biegel JA; Hatanpaa KJ; Judkins A; White CL; Perry A
    Brain Pathol; 2005 Jan; 15(1):23-8. PubMed ID: 15779233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.